ScholarLens Back to search
2007•Unpublished venueRequires access

Role of Combined Testing of Tumor Markers CA19-9 and CEA and CA242 in the Diagnosis and Evaluate Prognosis of Pancreatic Carcinoma

Wang Li

Open publisher page 0 citations

Abstract

Objective To explore the value of combined testing of tumor markers CA19-9 and CEA and CA242 in the diagnosis of pancreatic carcinoma.Methods Detection of serum tumor markers CA19-9 and CEA and CA242 was carried out in 98 patients with pancreatic carcinoma and 60 healthy volunteers.Results The levels of tumor markers in pancreatic carcinoma group were significantly higher than those in the normal contral group.Conclusion THe combined testing of tumor markers CA19-9 and CEA and CA242 is an ideal markers in the diagnosis and the follow-up of operated cases and evaluate prognosis of pancreatic carcinoma.

About this research paper

What this paper is about

Objective To explore the value of combined testing of tumor markers CA19-9 and CEA and CA242 in the diagnosis of pancreatic carcinoma.Methods Detection of serum tumor markers CA19-9 and CEA and CA242 was carried out in 98 patients with pancreatic carcinoma and 60 healthy volunteers.Results The levels of tumor markers in pancreatic carcinoma group were significantly higher than those in the normal contral group.Conclusion THe combined testing of tumor markers CA19-9 and CEA and CA242 is an ideal markers in the diagnosis and the follow-up of operated cases and evaluate prognosis of pancreatic carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the value of combined testing of tumor markers CA19-9 and CEA and CA242 in the diagnosis of pancreatic carcinoma.Methods Detection of serum tumor markers CA19-9 and CEA and CA242 was carried out in 98 patients with pancreatic carcinoma and 60 healthy volunteers.Results The levels of tumor markers in pancreatic carcinoma group were significantly higher than those in the normal contral group.Conclusion THe combined testing of tumor markers CA19-9 and CEA and CA242 is an ideal markers in the diagnosis and the follow-up of operated cases and evaluate prognosis of pancreatic carcinoma.

Key concepts: CA19-9, Tumor marker, Medicine, Pancreatic carcinoma, Internal medicine, Carcinoma, Tumor M2-PK, Pancreatic cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Role of Combined Testing of Tumor Markers CA19-9 and CEA and CA242 in the Diagnosis and Evaluate Prognosis of Pancreatic Carcinoma — Research Paper | ScholarLens